Allianz Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.61M | Buy |
271,100
+47,700
| +21% | +$1.27M | 0.01% | 985 |
|
|
2025
Q4 | $5.56M | Buy |
223,400
+36,900
| +20% | +$931K | 0.01% | 1091 |
|
|
2025
Q3 | $4.75M | Sell |
186,500
-78,100
| -30% | -$1.93M | 0.01% | 1137 |
|
|
2025
Q2 | $6.41M | Buy |
264,600
+33,100
| +14% | +$772K | 0.01% | 988 |
|
|
2025
Q1 | $5.87M | Sell |
231,500
-100
| -0% | -$2.62K | 0.01% | 1026 |
|
|
2024
Q4 | $6.14M | Sell |
231,600
-74,300
| -24% | -$2.02M | 0.01% | 950 |
|
|
2024
Q3 | $8.85M | Buy |
305,900
+174,700
| +133% | +$5.1M | 0.01% | 790 |
|
|
2024
Q2 | $3.67M | Buy |
131,200
+119,900
| +1,061% | +$3.3M | 0.01% | 1093 |
|
|
2024
Q1 | $314K | Sell |
11,300
-186,100
| -94% | -$5.16M | ﹤0.01% | 1736 |
|
|
2023
Q4 | $5.68M | Sell |
197,400
-262,500
| -57% | -$7.94M | 0.01% | 867 |
|
|
2023
Q3 | $15.3M | Buy |
459,900
+288,600
| +168% | +$10.2M | 0.03% | 571 |
|
|
2023
Q2 | $6.28M | Sell |
171,300
-196,500
| -53% | -$7.65M | 0.01% | 785 |
|
|
2023
Q1 | $15M | Buy |
367,800
+3,300
| +0.9% | +$143K | 0.03% | 566 |
|
|
2022
Q4 | $18.7M | Buy |
364,500
+44,900
| +14% | +$2.15M | 0.04% | 489 |
|
|
2022
Q3 | $14M | Buy |
319,600
+262,000
| +455% | +$12.7M | 0.03% | 559 |
|
|
2022
Q2 | $3.02M | Sell |
57,600
-199,800
| -78% | -$10.2M | ﹤0.01% | 1272 |
|
|
2022
Q1 | $13.3M | Buy |
257,400
+22,500
| +10% | +$1.17M | 0.01% | 892 |
|
|
2021
Q4 | $13.9M | Sell |
234,900
-146,400
| -38% | -$7.25M | 0.01% | 883 |
|
|
2021
Q3 | $16.4M | Buy |
381,300
+244,300
| +178% | +$10.8M | 0.01% | 811 |
|
|
2021
Q2 | $5.37M | Buy |
137,000
+19,900
| +17% | +$774K | ﹤0.01% | 1084 |
|
|
2021
Q1 | $4.24M | Buy |
+117,100
| New | +$4.16M | ﹤0.01% | 1133 |
|
|
2020
Q3 | – | Sell |
-273,829
| Closed | -$8.49M | – | 2274 |
|
|
2020
Q2 | $8.49M | Sell |
273,829
-125,848
| -31% | -$4.28M | 0.01% | 967 |
|
|
2020
Q1 | $12.4M | Sell |
399,677
-571,162
| -59% | -$19.5M | 0.02% | 758 |
|
|
2019
Q4 | $36.1M | Sell |
970,839
-50,698
| -5% | -$1.81M | 0.03% | 533 |
|
|
2019
Q3 | $34.8M | Buy |
1,021,537
+140,288
| +16% | +$5.1M | 0.03% | 556 |
|
|
2019
Q2 | $36.2M | Sell |
881,249
-51,752
| -6% | -$2.05M | 0.03% | 556 |
|
|
2019
Q1 | $37.6M | Sell |
933,001
-1,408,249
| -60% | -$56.4M | 0.04% | 495 |
|
|
2018
Q4 | $97M | Buy |
2,341,250
+306,714
| +15% | +$12.7M | 0.11% | 201 |
|
|
2018
Q3 | $85.1M | Sell |
2,034,536
-294,277
| -13% | -$11.3M | 0.08% | 283 |
|
|
2018
Q2 | $80.2M | Sell |
2,328,813
-120,261
| -5% | -$4.11M | 0.08% | 281 |
|
|
2018
Q1 | $82.5M | Sell |
2,449,074
-1,772,512
| -42% | -$60.9M | 0.08% | 282 |
|
|
2017
Q4 | $145M | Sell |
4,221,586
-249,798
| -6% | -$8.52M | 0.11% | 205 |
|
|
2017
Q3 | $151M | Buy |
4,471,384
+363,735
| +9% | +$11.7M | 0.13% | 169 |
|
|
2017
Q2 | $131M | Buy |
4,107,649
+6,957
| +0.2% | +$219K | 0.13% | 183 |
|
|
2017
Q1 | $133M | Sell |
4,100,692
-2,373,187
| -37% | -$74.8M | 0.13% | 173 |
|
|
2016
Q4 | $199M | Buy |
6,473,879
+1,569,828
| +32% | +$47.9M | 0.18% | 118 |
|
|
2016
Q3 | $158M | Buy |
4,904,051
+1,212,732
| +33% | +$40.6M | 0.15% | 145 |
|
|
2016
Q2 | $123M | Buy |
3,691,319
+1,758,705
| +91% | +$56.1M | 0.13% | 173 |
|
|
2016
Q1 | $54.3M | Sell |
1,932,614
-85,796
| -4% | -$2.45M | 0.06% | 326 |
|
|
2015
Q4 | $61.8M | Buy |
2,018,410
+637,038
| +46% | +$20M | 0.07% | 299 |
|
|
2015
Q3 | $41.2M | Sell |
1,381,372
-577,065
| -29% | -$18.5M | 0.05% | 454 |
|
|
2015
Q2 | $62.3M | Buy |
1,958,437
+154,938
| +9% | +$5.05M | 0.07% | 340 |
|
|
2015
Q1 | $59.5M | Sell |
1,803,499
-322,208
| -15% | -$10.2M | 0.07% | 318 |
|
|
2014
Q4 | $62.8M | Buy |
2,125,707
+1,329,305
| +167% | +$38.1M | 0.07% | 324 |
|
|
2014
Q3 | $22.3M | Buy |
796,402
+790,605
| +13,638% | +$22.2M | 0.03% | 606 |
|
|
2014
Q2 | $163K | Buy |
+5,797
| New | +$165K | ﹤0.01% | 1819 |
|
|
2013
Q3 | – | Sell |
-1,317,500
| Closed | -$35M | – | 1827 |
|
|
2013
Q2 | $35M | Buy |
+1,317,500
| New | +$36.4M | 0.05% | 390 |
|
Other funds holding PFE
VCM
VPM
Allianz Asset Management's PFE Position: Q1 2026 in Review
Allianz Asset Management reduced its Pfizer (PFE) stake by 4.1% in Q1 2026, selling an estimated $6.17M and leaving 5,490,142 shares worth $154M. The position accounts for 0.16% of the portfolio, ranked #121.
Allianz Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $942M in Q2 2013. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Allianz Asset Management held 5,490,142 shares of Pfizer worth $154M as of Q1 2026.
- Allianz Asset Management sold 231,784 Pfizer shares in Q1 2026, an estimated $6.17M.
- Pfizer made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #121 holding.
- Allianz Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Pfizer position peaked at $942M in Q2 2013.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.